|

Olaparib (300 mg BID) Clinical Trials

2 actively recruiting trials

Also known as: Open cohort

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Gustave Roussy, Cancer Campus, Grand Paris1
  • Centre Leon Berard1

Indications

  • Cancer2
  • Malignant Solid Neoplasms1
  • p53abn1
  • Endometrial Cancer1

Other2 trials

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
Phase 2
Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.